{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:20:21Z","timestamp":1710735621344},"reference-count":17,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":6311,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1990,12]]},"abstract":"<jats:p><jats:bold>S<jats:sc>ummary<\/jats:sc><\/jats:bold> Febrile neutropenic patients were randomized to receive ceftazidime and ciprofloxacin with the addition of teicoplanin in cases with clinical suspicion of a Hickman line\u2010associated infection. At 48 h both clinical and bacteriological analyses were made. Patients were categorized as: success, in cases of improvement or stability in the clinical condition: failure, if there was a deterioration of the clinical condition; and non\u2010evaluable, in cases of protocol violation or death due to other causes.<\/jats:p><jats:p>A total of 86 patients have completed the study so far: 43 patients were randomized to the ceftazidime and 43 to the ciprofloxacin group. Teicoplanin was added to the mono\u2010therapy in 12 patients in the ceftazidime group and 15 in the ciprofloxacin group. The diagnoses were: acute myelogenous leukaemia (25), non\u2010Hodgkin's lymphoma (34), Hodgkin's disease (17); acute lymphoblastic leukaemia (9) and chronic granulocytic leukaemia (1).<\/jats:p><jats:p>Forty\u2010eight hour clinical assessment showed a response rate in the ceftazidime group of: success 18\/31 (58%). failure 13\/31 (42%): in the ceftazidime and teicoplanin group: success 8\/12 (67%), failure 4\/12 (33%): in the ciprofloxacin group: success 23\/28 (82%). failure 5\/28 (18%): and in the ciprofloxacin and teicoplanin group: success 11\/15 (73%), failure 4\/15 (27%).<\/jats:p><jats:p>Blood cultures were positive in 48\/86 (56%) cases, with more than one organism isolated in seven of these 48 cases. Organisms isolated were: coagulase\u2010negative staphylococci (20), <jats:italic>Escherichia coli<\/jats:italic> (13), <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (4). <jats:italic>Staphylococcus aureus<\/jats:italic> (3), diphtheroids (3), <jats:italic>Klebsiella<\/jats:italic> sp. (3), <jats:italic>Enterobacter cloacue<\/jats:italic> (2), <jats:italic>Streptococcus faecalis<\/jats:italic> (2). Ent. <jats:italic>adenocarboxylata<\/jats:italic> (1). <jats:italic>Clostridium septicum<\/jats:italic> (1). <jats:italic>Strept<\/jats:italic>. B (1). alpha streptococcus (1) and P. <jats:italic>fluorescens<\/jats:italic> (1). <jats:italic>In\u2010vitro<\/jats:italic> testing showed that all Gram\u2010positive organisms were sensitive to teicoplanin, and Gram\u2010negative organisms to ciprofloxacin or ceftazidime. There were seven cases of superimposed infections with eight organisms isolated, all cases occurring in patients receiving ciprofloxacin alone: coagulase\u2010negative staphylococci (4). <jats:italic>Strep. sangius<\/jats:italic> (1). <jats:italic>Strep. viridans<\/jats:italic> (1), diphtheroids (1) and P. m<jats:italic>altophilia<\/jats:italic> (1). Both ciprofloxacin and ceftazidime are comparable in efficacy as empirical mono\u2010therapy for febrile neutropenic patients. There is, however, a significant increase in the incidence of superimposed infection in patients receiving only ciprofloxacin. In view of the very high incidence of Gram\u2010positive septicaemia, we suggest that teicoplanin should be added as part of the initial empiric antibiotic regimen in all febrile neutropenic patients.<\/jats:p>","DOI":"10.1111\/j.1365-2141.1990.tb07935.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T11:09:40Z","timestamp":1205320180000},"page":"41-44","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients"],"prefix":"10.1111","volume":"76","author":[{"given":"S. H.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Machin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.SD.187"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.6.824"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-1-7"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.1.138"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.3.295"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.suppl_B.1"},{"key":"e_1_2_1_8_1","unstructured":"Kinsey S.E. Machin S.J.&Goidstone A.H.(1988)The role of ceftazidime as empirical therapy for febrile neutropenic patients with haematological malignancy. In:Proceedings of 5th Immuno\u2010compromised Host Society Holland."},{"key":"e_1_2_1_9_1","unstructured":"Kinsey S.E. Machin S.J.&Goldstone A.H.(1989)Hickman catheter related sepsis in neutropenia.Koyal Society of Medicine (International Congress and Symposium Series). pp.145\u2013153."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/4.2.294"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150905"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198205000-00003"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.1.104"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-30"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197105132841904"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1193"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-4-503"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archinte.1983.00350010034007","article-title":"Coagulase\u2010negative staphylococcal bacteremia in patients receiving immunosuppressive therapy","volume":"143","author":"Winston D.J.","year":"1983","journal-title":"Archives of Internal Medicine"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1990.tb07935.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1990.tb07935.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:08:46Z","timestamp":1695737326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1990.tb07935.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":17,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["10.1111\/j.1365-2141.1990.tb07935.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1990.tb07935.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}